Paperless Partograph for Management of Low Risk Labor
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02714270 |
Recruitment Status :
Completed
First Posted : March 21, 2016
Last Update Posted : August 2, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Paperless partograph is a technique used for monitoring the progress of labor before delivery, and arriving at the accurate time to intervene for ensuring a safe delivery.
The study will be carried out to find out the effectiveness of paperless partograph in management of labor and its effect on maternal and neonatal outcomes
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Normal Labor | Procedure: modified partograph Procedure: paperless partograph | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 370 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Supportive Care |
Official Title: | A Randomized Clinical Trial of Paperless Versus Modified World Health Organization Partograph in Management of First Stage of Labour |
Actual Study Start Date : | December 2016 |
Actual Primary Completion Date : | March 2018 |
Actual Study Completion Date : | June 2018 |
Arm | Intervention/treatment |
---|---|
Active Comparator: modified partograph
routine modified partograph
|
Procedure: modified partograph |
Active Comparator: paperless partograph
paperless partograph with no graph paper
|
Procedure: paperless partograph |
- Duration of active phase of labor [ Time Frame: 12 hours ]calculated in hours between cervical dilatation more than 3 cm till fully dilated

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 40 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
- Age: 18 to 40 years
- Gestational age 38-42 weeks
- Singleton pregnancy
- Vertex presentation
- Women who will accept to participate in the study
Exclusion criteria:
- Malpresentation
- Induced labour
- Multiple pregnancy
- Medical diseases with pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02714270
Egypt | |
Ahmed Abbas | |
Assiut, Cairo, Egypt, 002 |
Responsible Party: | Ahmed Mohamed Abbas, Dr, Assiut University |
ClinicalTrials.gov Identifier: | NCT02714270 |
Other Study ID Numbers: |
WHOP-PP |
First Posted: | March 21, 2016 Key Record Dates |
Last Update Posted: | August 2, 2018 |
Last Verified: | August 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |